Valerio Therapeutics Société anonyme (ALVIO.PA) Stock Price

€0.058 1.7%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    6
  • Fundamental

    3
  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Valerio Therapeutics Société anonyme, AI stock picks, stock alerts and much more.

Sign up

ALVIO.PA AI Stock Analysis

AI stock analysis for ALVIO.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Valerio Therapeutics Société anonyme (ALVIO.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Valerio Therapeutics Société anonyme (ALVIO.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Valerio Therapeutics Société anonyme (ALVIO.PA), currently trading at €0.058, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ALVIO.PA

LSE
  • Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide.

  • Symbol

    ALVIO.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    8.9M

Similar Stocks

VLA.PA Valneva SE
VLA.PA
€3.39
9.8%
4
TUB.BR Financière de Tubize SA
TUB.BR
€149.2
1.2%
7
OSE.PA OSE Immunotherapeutics SA
OSE.PA
€6.55
2.8%
6
UCB.BR UCB SA
UCB.BR
€185.3
0.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA
€2.03
5.1%
5

News

No news articles.

ALVIO.PA Alternative Data

Web Traffic

Valerio Therapeutics Société anonyme receives an estimated 1951 monthly visitors to valeriotx.com.

  • Web Traffic

    1951

  • Change from Previous Month

    473.8%

  • 3 Month Change

    572.8%

News Mentions

Valerio Therapeutics Société anonyme was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Valerio Therapeutics Société anonyme has 5 Twitter Followers on its main Twitter (also known as X) account.

  • Twitter Followers

    5

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    92.4%

Job Postings

Valerio Therapeutics Société anonyme currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

LinkedIn Employees

According to LinkedIn, Valerio Therapeutics Société anonyme has 61 employees, down by -4.7% over the last month.

  • LinkedIn Employees

    61

  • Daily Change

    0%

  • 1 Month Change

    4.7%

  • 3 Month Change

    7.6%

ALVIO.PA Financials

ALVIO.PA Key Metrics
  • Total Revenue

    €44.5K

  • Net Income

    -€5.5M

  • Earnings per Share

    -€0.0334

  • Free cash flow

    -€3.4M

  • EBITDA

    -€4.7M

  • EBITDA Ratio

    -105.921

  • Total Assets

    €29.3M

ALVIO.PA 2-year Revenue & Income
ALVIO.PA 2-year Free Cash Flow

ALVIO.PA Technicals

ALVIO.PA SMA
ALVIO.PA RSI

FAQ

What's the current price of Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
The price of an Valerio Therapeutics Société anonyme (ALVIO.PA) share is €0.058.

What's the market cap of Valerio Therapeutics Société anonyme?
The current market cap of Valerio Therapeutics Société anonyme is 8.9M.

Should I buy or sell ALVIO.PA?
Valerio Therapeutics Société anonyme shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Valerio Therapeutics Société anonyme is better viewed as a hold or accumulate position while waiting for further developments.

Is Valerio Therapeutics Société anonyme a good investment?
The current analysis of Valerio Therapeutics Société anonyme's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Valerio Therapeutics Société anonyme's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Valerio Therapeutics Société anonyme stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Valerio Therapeutics Société anonyme (ALVIO.PA) that investors often compare it to?
Valerio Therapeutics Société anonyme (ALVIO.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for Valerio Therapeutics Société anonyme's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Valerio Therapeutics Société anonyme's stock price to be around €0.055 in 2026. Starting from the current price of €0.058, this represents a 5.2% change in price, indicating a bearish outlook for the stock.

How to buy Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
Valerio Therapeutics Société anonyme stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Valerio Therapeutics Société anonyme shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.